SCHEMBL3756039

SCHEMBL3756039

O=C=Nc1cccc2c1OCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.40
GSK3B P49841 1/20 0.38
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
MAOB P27338 3/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
AOC3 Q16853 2/20 0.35
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
EED O75530 1/20 0.33
TXNRD1 Q16881 1/20 0.33
TXNRD3 Q86VQ6 1/20 0.33
TXNRD2 Q9NNW7 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
CHEK1 O14757 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10175066 0.86 CYP3A4 (0.46) CYP3A4KDM4ELMNA
SCHEMBL31135849 0.86 CYP3A4 (0.46) CYP3A4KDM4ELMNA
SCHEMBL6818743 0.82 ALDH1A1 (0.42) CYP3A4ABCG2GSK3BPKMTSHR
SCHEMBL3544842 0.76 AOC3 (0.36) CYP3A4MAOBGABRA1GABRB2AOC3
SCHEMBL28285 0.76 ABCG2 (0.44) ABCG2GSK3BPKMTSHRMAOB
SCHEMBL18007675 0.70 PARP1 (0.47) CYP3A4GABRA1GABRB2
SCHEMBL11196197 0.69 EED (0.43) ABCG2GSK3BPKMTSHRPOLB
SCHEMBL9186004 0.69 HTT (0.31)
SCHEMBL10083072 0.69 CYP3A4 (0.43) CYP3A4GABRA1GABRB2
SCHEMBL1145960 0.69 ABCG2 (0.50) ABCG2GSK3BPKMTSHRMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298366-A1 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORPORATION (US) 2010-11-25 US disclosed
US-20090099205-A1 Chemokine receptor binding compounds GENZYME CORPORATION 2009-04-16 US disclosed
EP-1603897-A1 PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2005-12-14 EP disclosed
WO-2004080999-A1 PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298366-A1 CHEMOKINE RECEPTOR BINDING COMPOUNDS CCR5, CXCR3, CCL5 CYP3A4 3526/4885ABCG2 702/4885GSK3B 674/4885
US-20090099205-A1 Chemokine receptor binding compounds CCR5, CXCR3, CCL5 CYP3A4 3526/4885ABCG2 702/4885GSK3B 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.